FI59801C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-(laegre alkyl)-4-oxo-5-piperidino-tiazolidin-2-yliden-aettiksyraderivat - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-(laegre alkyl)-4-oxo-5-piperidino-tiazolidin-2-yliden-aettiksyraderivat Download PDF

Info

Publication number
FI59801C
FI59801C FI750895A FI750895A FI59801C FI 59801 C FI59801 C FI 59801C FI 750895 A FI750895 A FI 750895A FI 750895 A FI750895 A FI 750895A FI 59801 C FI59801 C FI 59801C
Authority
FI
Finland
Prior art keywords
acid
oxo
piperidino
thiazolidin
alkyl
Prior art date
Application number
FI750895A
Other languages
English (en)
Finnish (fi)
Other versions
FI59801B (fi
FI750895A (US07902200-20110308-C00004.png
Inventor
Gerhard Satzinger
Manfred Franz Reinhol Herrmann
Karl-Otto Vollmer
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2414345A external-priority patent/DE2414345C3/de
Priority claimed from DE2506410A external-priority patent/DE2506410C3/de
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI750895A publication Critical patent/FI750895A/fi
Publication of FI59801B publication Critical patent/FI59801B/fi
Application granted granted Critical
Publication of FI59801C publication Critical patent/FI59801C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54Nitrogen and either oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI750895A 1974-03-25 1975-03-25 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-(laegre alkyl)-4-oxo-5-piperidino-tiazolidin-2-yliden-aettiksyraderivat FI59801C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2414345 1974-03-25
DE2414345A DE2414345C3 (de) 1974-03-25 1974-03-25 (Z)-(3-Methyl-4-oxo-5-piperidinothiazolidin-2-yIiden)-esssigsäure und Verfahren zur Herstellung von Thiazolidinessigsäure-Derivaten
DE2506410 1975-02-15
DE2506410A DE2506410C3 (de) 1975-02-15 1975-02-15 Verfahren zur Herstellung von Thiazolidinon-essigsäure-Derivaten

Publications (3)

Publication Number Publication Date
FI750895A FI750895A (US07902200-20110308-C00004.png) 1975-09-26
FI59801B FI59801B (fi) 1981-06-30
FI59801C true FI59801C (fi) 1981-10-12

Family

ID=25766870

Family Applications (1)

Application Number Title Priority Date Filing Date
FI750895A FI59801C (fi) 1974-03-25 1975-03-25 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-(laegre alkyl)-4-oxo-5-piperidino-tiazolidin-2-yliden-aettiksyraderivat

Country Status (10)

Country Link
AT (1) AT340416B (US07902200-20110308-C00004.png)
CH (1) CH594664A5 (US07902200-20110308-C00004.png)
DK (1) DK140725B (US07902200-20110308-C00004.png)
ES (1) ES435930A1 (US07902200-20110308-C00004.png)
FI (1) FI59801C (US07902200-20110308-C00004.png)
FR (1) FR2265375B1 (US07902200-20110308-C00004.png)
GB (1) GB1437170A (US07902200-20110308-C00004.png)
NL (1) NL7503395A (US07902200-20110308-C00004.png)
NO (1) NO141801C (US07902200-20110308-C00004.png)
SE (1) SE415352B (US07902200-20110308-C00004.png)

Also Published As

Publication number Publication date
NO750983L (US07902200-20110308-C00004.png) 1975-09-26
CH594664A5 (US07902200-20110308-C00004.png) 1978-01-13
NO141801C (no) 1980-06-04
DK140725B (da) 1979-11-05
GB1437170A (US07902200-20110308-C00004.png) 1976-05-26
SE415352B (sv) 1980-09-29
FR2265375B1 (US07902200-20110308-C00004.png) 1978-08-04
FI59801B (fi) 1981-06-30
ATA229075A (de) 1977-04-15
NL7503395A (nl) 1975-09-29
DK108675A (US07902200-20110308-C00004.png) 1975-09-26
SE7503380L (US07902200-20110308-C00004.png) 1975-09-26
AT340416B (de) 1977-12-12
NO141801B (no) 1980-02-04
ES435930A1 (es) 1977-03-16
FI750895A (US07902200-20110308-C00004.png) 1975-09-26
FR2265375A1 (US07902200-20110308-C00004.png) 1975-10-24
DK140725C (US07902200-20110308-C00004.png) 1980-03-31

Similar Documents

Publication Publication Date Title
US4582847A (en) 4-chloro-2-phenylimidazole-5-acetic acid derivatives and use as diuretics and hypotensives
PT101875B (pt) Derivados de benzeno e processo para a sua preparacao
JP2003012686A (ja) ピラゾール誘導体
IE871462L (en) Benzopyran derivatives
KR20100083195A (ko) 신규한 디아제니움디올레이트 유도체, 이들의 제조 방법 및 상기 화합물을 포함하는 약제 조성물
HU193409B (en) Process for producing 2-square bracket -n-cyclohexyl-4-bracket-oxo-1,2,3,5-tetrahydro-imidazo-square bracket-2,1-b-square bracket closed-quinazolin-7-yl-bracket closed-oxy-alkqne-carboxamidyl-square bracket closed-alkan-acides
FI59801C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-(laegre alkyl)-4-oxo-5-piperidino-tiazolidin-2-yliden-aettiksyraderivat
WO1994002457A1 (en) Prostaglandin derivative
US3979408A (en) 2-(Pyrrol-1-yl)amino-4,5-dihydro-1H-imidazole derivatives
IE68851B1 (en) Quinoxalinone derivatives
US4012395A (en) Process for preparing thiazolidinone acetic acid derivatives
US3971794A (en) Thiazolidinone acetic acid derivatives
US3914219A (en) 3-Alkyl-4-sulfamoyl-aniline compounds
US4041166A (en) Method of producing diuresis using thiazolidinone acetic acid derivatives
US4001417A (en) Method for producing diuresis in a mammal by use of thiazolidinone acetic acid derivatives
US4039671A (en) Method for producing diuresis by administering certain thiazolidinone acetic acid derivatives
US4364867A (en) N-(1-Methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulfamoyl benzamide and its derivatives
CH637650A5 (fr) Procede de preparation d'un acide chromone carboxylique.
EP0076952A1 (en) N-acyl-3-(4-(benzoylalkyl)piperazin-1-yl)-sydnonimine compound, process for production thereof, and use thereof
JPS63264580A (ja) 3−(2−ハロアルキル)−1,4−オキサチインおよび2−(2−ハロアルキル)−1,4−ジチイン
US4588723A (en) Aminoalkyl-imidazothiadiazole-alkenecarboxylic acid amides, intermediates for their preparation and their use in medicaments
KR950008316B1 (ko) 1-히드록시-5-옥소-5H-피리도[3,2-a]페녹사진-3-카르복실산 에스테르
IE41805B1 (en) Thiazolidinone-acetic acid derivatives
SU1676452A3 (ru) Способ получени производных фуробензизоксазола
US3991188A (en) 3-Alkyl-4-sulfamoyl-aniline therapeutic compositions

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: WARNER-LAMBERT COMPANY